Mesenchymal Stem Cells: A New Generation of Therapeutic Agents as Vehicles in Gene Therapy.

Current Gene Therapy
Mahmoud GharbaviSaeed Ghanbarzadeh

Abstract

In recent years, mesenchymal stem cells (MSCs) as a new tool for therapeutic gene delivery in clinics have attracted much attention. Their advantages cover longer lifespan, better isolation, and higher transfection efficiency and proliferation rate. MSCs are the preferred approach for cell-based therapies because of their in vitro self-renewal capacity, migrating especially to tumor tissues, as well as anti-inflammatory and immunomodulatory properties. Therefore, they have considerable efficiency in genetic engineering for future clinical applications in cancer gene therapy and other diseases. For improving therapeutic efficiency, targeted therapy of cancers can be achieved through the sustained release of therapeutic agents and functional gene expression induction to the intended tissues. The development of a new vector in gene therapy can improve the durability of a transgene expression. Also, the safety of the vector, if administered systemically, may resolve several problems, such as durability of expression and the host immune response. Currently, MSCs are prominent candidates as cell vehicles for both preclinical and clinical trials due to the secretion of therapeutic agents in several cancers. In the present study, we di...Continue Reading

References

Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·P L FelgnerM Danielsen
Feb 7, 1996·Transfusion Science·K E Matthews, A Keating
Apr 5, 2000·Nature Biotechnology·B E ReubinoffA Bongso
Mar 30, 2001·Bone Marrow Transplantation·O N Koç, H M Lazarus
Apr 3, 2001·Nature Medicine·D J AndersonI L Weissman
May 23, 2001·Leukemia·V F Van TendelooZ N Berneman
Dec 6, 2001·Current Drug Targets·M Johnson-Saliba, D A Jans
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·C P HofstetterL Olson
Mar 7, 2002·American Journal of Physiology. Lung Cellular and Molecular Physiology·Allen C MyersBradley J Undem
Mar 20, 2002·Nature Reviews. Cancer·M J Bissell, D Radisky
Aug 16, 2002·American Journal of Physiology. Gastrointestinal and Liver Physiology·Matthew Bjerknes, Hazel Cheng
Sep 28, 2002·International Immunopharmacology·Antonio SicaAlberto Mantovani
Feb 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Jeffrey L SpeesDarwin J Prockop
Apr 30, 2003·Applied Microbiology and Biotechnology·M Thomas, A M Klibanov
May 3, 2003·Nature Reviews. Genetics·Clare E ThomasMark A Kay
Aug 21, 2004·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Ryang Hwa LeeJin Sup Jung
Nov 4, 2004·Journal of the National Cancer Institute·Matus StudenyMichael Andreeff
Nov 30, 2004·Science·Jeanmarie HoughtonTimothy C Wang
Dec 21, 2004·International Journal of Pharmaceutics·Savita BishtAmarnath Maitra
Feb 23, 2005·Current Pharmaceutical Design·B MartinP Lehn
Feb 25, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Abdelatif Elouahabi, Jean-Marie Ruysschaert
Mar 5, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Julia SmithShant Kumar
Apr 19, 2005·Cancer Research·Akira NakamizoFrederick F Lang
Jul 9, 2005·Environmental Health Perspectives·Günter OberdörsterJan Oberdörster
Jul 12, 2005·The Journal of Clinical Investigation·Diane Krause, Lloyd G Cantley
Sep 6, 2005·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Denise ShirleyGang Li
Mar 4, 2006·Molecular Cancer Research : MCR·Rob CairnsNicholas Denko
Mar 21, 2006·Molecular Cancer Therapeutics·Svetlana KomarovaLarisa Pereboeva
Apr 4, 2006·Nature Medicine·Yoshinori MiyaharaHidezo Mori
Apr 26, 2006·The Journal of Experimental Medicine·Aarif Y KhakooToren Finkel
May 11, 2006·Journal of Cell Science·Lindolfo da Silva MeirellesNance Beyer Nardi

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Byung Woo HwangSei Kwang Hahn
American Journal of Physiology. Heart and Circulatory Physiology
Cheng-Huang SuHung-I Yeh
Methods in Molecular Biology
Yu-Lan Hu, Jian-Qing Gao
© 2022 Meta ULC. All rights reserved